Orthofix International | OFIX - Sales Revenues


Orthofix International reported $219.91M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 141.2M 700K Mar/2026
Dexcom USD 1.19B 70M Mar/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
Globus Medical USD 759.85M 66.55M Mar/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Smith & Nephew USD 3.18B 353M Dec/2025
STAAR Surgical USD 93.5M 145.9M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Surmodics USD 29.57M 355K Jun/2025
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Veracyte USD 139.07M 1.53M Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026